Company intelligence
CiteMed
Clinical evidence, simplified for regulatory success | A FuzionX Co-Build Company
Medical Equipment Manufacturing
Chicago, US
8 employees
Founded 2017
5 public signals
About CiteMed
CiteMed is a clinical evidence platform designed to simplify regulatory literature review. Our platform streamlines Clinical Evaluation Reports, modular reviews, and post-market surveillance into one structured workflow with regulatory-ready outputs.
Verified activity
Signals from CiteMed
5 published signals
Presence & Recognition
CiteMed is attending RAPS Convergence 2026 in Charlotte at Booth 805 to discuss clinical evidence, post-market surveillance, regulatory strategy, and evidence workflows.
Reported by CiteMed
Presence & Recognition
CiteMed will be attending RAPS Convergence 2026 at Booth 805 in Charlotte, discussing clinical evidence, post-market surveillance, and Evidence Cloud.
Reported by Ethan Drower
Research & Knowledge
CiteMed published the latest edition of The CiteMed Signal, focusing on post-market surveillance under EU MDR and a distinction between PSUR and PMSR.
Reported by CiteMed
Research & Knowledge
CiteMed has written a detailed breakdown covering the PSUR vs PMSR distinction, reporting requirements under EU MDR Articles 85 and 86, and what Notified Bodies are looking for when they review these documents.
Reported by CiteMed
Products & Services
CiteMed built Evidence Cloud to provide a connected platform across the full lifecycle for systematic review tools including search, screening, extraction, reporting, surveillance, and audit trails.
Reported by CiteMed